Credit Suisse’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-57,864
| Closed | -$250K | – | 3145 |
|
|
2023
Q3 | $250K | Sell |
57,864
-12,853
| -18% | -$55.5K | ﹤0.01% | 2975 |
|
|
2023
Q2 | $466K | Buy |
70,717
+21,355
| +43% | +$141K | ﹤0.01% | 2804 |
|
|
2023
Q1 | $335K | Buy |
49,362
+15
| +0% | +$102 | ﹤0.01% | 2934 |
|
|
2022
Q4 | $365K | Sell |
49,347
-7,977
| -14% | -$59K | ﹤0.01% | 2927 |
|
|
2022
Q3 | $566K | Buy |
57,324
+322
| +0.6% | +$3.18K | ﹤0.01% | 2697 |
|
|
2022
Q2 | $621K | Sell |
57,002
-3,482
| -6% | -$37.9K | ﹤0.01% | 2691 |
|
|
2022
Q1 | $684K | Sell |
60,484
-917
| -1% | -$10.4K | ﹤0.01% | 2776 |
|
|
2021
Q4 | $964K | Buy |
61,401
+224
| +0.4% | +$3.52K | ﹤0.01% | 2610 |
|
|
2021
Q3 | $1.05M | Buy |
61,177
+609
| +1% | +$10.4K | ﹤0.01% | 2546 |
|
|
2021
Q2 | $1.3M | Sell |
60,568
-6,318
| -9% | -$136K | ﹤0.01% | 2456 |
|
|
2021
Q1 | $1.01M | Sell |
66,886
-21,579
| -24% | -$324K | ﹤0.01% | 2576 |
|
|
2020
Q4 | $1.16M | Sell |
88,465
-18,154
| -17% | -$238K | ﹤0.01% | 2487 |
|
|
2020
Q3 | $1.03M | Sell |
106,619
-9,161
| -8% | -$88.5K | ﹤0.01% | 2244 |
|
|
2020
Q2 | $1.33M | Buy |
115,780
+77,822
| +205% | +$891K | ﹤0.01% | 2144 |
|
|
2020
Q1 | $393K | Sell |
37,958
-9,010
| -19% | -$93.3K | ﹤0.01% | 2660 |
|
|
2019
Q4 | $770K | Buy |
46,968
+8,991
| +24% | +$147K | ﹤0.01% | 2675 |
|
|
2019
Q3 | $504K | Sell |
37,977
-10,150
| -21% | -$135K | ﹤0.01% | 2794 |
|
|
2019
Q2 | $678K | Sell |
48,127
-23,266
| -33% | -$328K | ﹤0.01% | 2605 |
|
|
2019
Q1 | $1.31M | Buy |
71,393
+29,452
| +70% | +$542K | ﹤0.01% | 2181 |
|
|
2018
Q4 | $1.1M | Buy |
41,941
+12,269
| +41% | +$321K | ﹤0.01% | 2217 |
|
|
2018
Q3 | $680K | Sell |
29,672
-33,329
| -53% | -$764K | ﹤0.01% | 2657 |
|
|
2018
Q2 | $1.2M | Buy |
63,001
+16,243
| +35% | +$309K | ﹤0.01% | 2464 |
|
|
2018
Q1 | $788K | Buy |
46,758
+5,431
| +13% | +$91.5K | ﹤0.01% | 2721 |
|
|
2017
Q4 | $628K | Sell |
41,327
-12,349
| -23% | -$188K | ﹤0.01% | 2828 |
|
|
2017
Q3 | $961K | Buy |
53,676
+8,942
| +20% | +$160K | ﹤0.01% | 2679 |
|
|
2017
Q2 | $729K | Sell |
44,734
-169,074
| -79% | -$2.76M | ﹤0.01% | 2533 |
|
|
2017
Q1 | $2.99M | Buy |
213,808
+27,252
| +15% | +$381K | ﹤0.01% | 1751 |
|
|
2016
Q4 | $2.98M | Sell |
186,556
-12,489
| -6% | -$199K | ﹤0.01% | 1835 |
|
|
2016
Q3 | $3.31M | Buy |
199,045
+94,558
| +90% | +$1.57M | ﹤0.01% | 1729 |
|
|
2016
Q2 | $1.17M | Buy |
104,487
+20,366
| +24% | +$228K | ﹤0.01% | 2522 |
|
|
2016
Q1 | $703K | Buy |
84,121
+45,525
| +118% | +$380K | ﹤0.01% | 2714 |
|
|
2015
Q4 | $359K | Buy |
38,596
+9,378
| +32% | +$87.2K | ﹤0.01% | 3363 |
|
|
2015
Q3 | $330K | Sell |
29,218
-169,854
| -85% | -$1.92M | ﹤0.01% | 3452 |
|
|
2015
Q2 | $2.53M | Buy |
199,072
+116,275
| +140% | +$1.48M | ﹤0.01% | 2138 |
|
|
2015
Q1 | $771K | Buy |
82,797
+3,753
| +5% | +$34.9K | ﹤0.01% | 2942 |
|
|
2014
Q4 | $1.13M | Buy |
79,044
+47,570
| +151% | +$681K | ﹤0.01% | 2697 |
|
|
2014
Q3 | $327K | Buy |
31,474
+8,239
| +35% | +$85.6K | ﹤0.01% | 3501 |
|
|
2014
Q2 | $376K | Sell |
23,235
-58,445
| -72% | -$946K | ﹤0.01% | 3561 |
|
|
2014
Q1 | $1.33M | Buy |
81,680
+41,035
| +101% | +$667K | ﹤0.01% | 2539 |
|
|
2013
Q4 | $504K | Buy |
40,645
+11,029
| +37% | +$137K | ﹤0.01% | 3354 |
|
|
2013
Q3 | $324K | Sell |
29,616
-1,371
| -4% | -$15K | ﹤0.01% | 3334 |
|
|
2013
Q2 | $250K | Buy |
+30,987
| New | +$250K | ﹤0.01% | 3347 |
|